BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35361920)

  • 21. Comparison of the frequency of loss-of-function LZTR1 variants between schwannomatosis patients and the general population.
    Deng F; Evans DG; Smith MJ
    Hum Mutat; 2022 Jul; 43(7):919-927. PubMed ID: 35391499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas.
    Hadfield KD; Smith MJ; Urquhart JE; Wallace AJ; Bowers NL; King AT; Rutherford SA; Trump D; Newman WG; Evans DG
    Oncogene; 2010 Nov; 29(47):6216-21. PubMed ID: 20729918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expanding the mutational spectrum of LZTR1 in schwannomatosis.
    Paganini I; Chang VY; Capone GL; Vitte J; Benelli M; Barbetti L; Sestini R; Trevisson E; Hulsebos TJ; Giovannini M; Nelson SF; Papi L
    Eur J Hum Genet; 2015 Jul; 23(7):963-8. PubMed ID: 25335493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Report of a patient with a constitutional missense mutation in SMARCB1, Coffin-Siris phenotype, and schwannomatosis.
    Gossai N; Biegel JA; Messiaen L; Berry SA; Moertel CL
    Am J Med Genet A; 2015 Dec; 167A(12):3186-91. PubMed ID: 26364901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening of potential novel candidate genes in schwannomatosis patients.
    Perez-Becerril C; Wallace AJ; Schlecht H; Bowers NL; Smith PT; Gokhale C; Eaton H; Charlton C; Robinson R; Charlton RS; Evans DG; Smith MJ
    Hum Mutat; 2022 Oct; 43(10):1368-1376. PubMed ID: 35723634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Updated protocol for genetic testing, screening and clinical management of individuals at risk of NF2-related schwannomatosis.
    Halliday D; Emmanouil B; Evans DGR
    Clin Genet; 2023 May; 103(5):540-552. PubMed ID: 36762955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Creation of an international registry to support discovery in schwannomatosis.
    Ostrow KL; Bergner AL; Blakeley J; Evans DG; Ferner R; Friedman JM; Harris GJ; Jordan JT; Korf B; Langmead S; Leschziner G; Mautner V; Merker VL; Papi L; Plotkin SR; Slopis JM; Smith MJ; Stemmer-Rachamimov A; Yohay K; Belzberg AJ
    Am J Med Genet A; 2017 Feb; 173(2):407-413. PubMed ID: 27759912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pain correlates with germline mutation in schwannomatosis.
    Jordan JT; Smith MJ; Walker JA; Erdin S; Talkowski ME; Merker VL; Ramesh V; Cai W; Harris GJ; Bredella MA; Seijo M; Suuberg A; Gusella JF; Plotkin SR
    Medicine (Baltimore); 2018 Feb; 97(5):e9717. PubMed ID: 29384852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies.
    Widemann BC; Acosta MT; Ammoun S; Belzberg AJ; Bernards A; Blakeley J; Bretscher A; Cichowski K; Clapp DW; Dombi E; Evans GD; Ferner R; Fernandez-Valle C; Fisher MJ; Giovannini M; Gutmann DH; Hanemann CO; Hennigan R; Huson S; Ingram D; Kissil J; Korf BR; Legius E; Packer RJ; McClatchey AI; McCormick F; North K; Pehrsson M; Plotkin SR; Ramesh V; Ratner N; Schirmer S; Sherman L; Schorry E; Stevenson D; Stewart DR; Ullrich N; Bakker AC; Morrison H
    Am J Med Genet A; 2014 Mar; 164A(3):563-78. PubMed ID: 24443315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinctive low epidermal nerve fiber density in schwannomatosis patients provides a major parameter for diagnosis and differential diagnosis.
    Farschtschi SC; Kluwe L; Schön G; Friedrich RE; Matschke J; Glatzel M; Weis J; Hagel C; Mautner VF
    Brain Pathol; 2020 Mar; 30(2):386-391. PubMed ID: 31424590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Rare Case of Familial Schwannomatosis Showing Intrafamilial Variability with Identification of a Shared Novel Germline
    Lee JH; Jeong JS; Chae KJ; Han YH; Kim SR; Lee YC
    Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36363549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.
    Mansouri S; Suppiah S; Mamatjan Y; Paganini I; Liu JC; Karimi S; Patil V; Nassiri F; Singh O; Sundaravadanam Y; Rath P; Sestini R; Gensini F; Agnihotri S; Blakeley J; Ostrow K; Largaespada D; Plotkin SR; Stemmer-Rachamimov A; Ferrer MM; Pugh TJ; Aldape KD; Papi L; Zadeh G
    Acta Neuropathol; 2021 Jan; 141(1):101-116. PubMed ID: 33025139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted massively parallel sequencing of candidate regions on chromosome 22q predisposing to multiple schwannomas: An analysis of 51 individuals in a single-center experience.
    Piotrowski A; Koczkowska M; Poplawski AB; Bartoszewski R; Króliczewski J; Mieczkowska A; Gomes A; Crowley MR; Crossman DK; Chen Y; Lao P; Serra E; Llach MC; Castellanos E; Messiaen LM
    Hum Mutat; 2022 Jan; 43(1):74-84. PubMed ID: 34747535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple primary malignancies associated with a germline SMARCB1 pathogenic variant.
    Eelloo JA; Smith MJ; Bowers NL; Ealing J; Hulse P; Wylie JP; Shenjere P; Clarke NW; Soh C; Whitehouse RW; Jones M; Duff C; Freemont A; Gareth Evans D
    Fam Cancer; 2019 Oct; 18(4):445-449. PubMed ID: 31240424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Segmental schwannomatosis in upper-extremity: 5 cases report and literature review].
    Wang ZX; Chen SL; Yi CJ; Li C; Rong YB; Tian GL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Oct; 45(5):698-703. PubMed ID: 24136261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multifocal nerve lesions and LZTR1 germline mutations in segmental schwannomatosis.
    Farschtschi S; Mautner VF; Pham M; Nguyen R; Kehrer-Sawatzki H; Hutter S; Friedrich RE; Schulz A; Morrison H; Jones DT; Bendszus M; Bäumer P
    Ann Neurol; 2016 Oct; 80(4):625-8. PubMed ID: 27472264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis.
    Hadfield KD; Newman WG; Bowers NL; Wallace A; Bolger C; Colley A; McCann E; Trump D; Prescott T; Evans DG
    J Med Genet; 2008 Jun; 45(6):332-9. PubMed ID: 18285426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas.
    Sestini R; Bacci C; Provenzano A; Genuardi M; Papi L
    Hum Mutat; 2008 Feb; 29(2):227-31. PubMed ID: 18072270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis.
    Fisher MJ; Belzberg AJ; de Blank P; De Raedt T; Elefteriou F; Ferner RE; Giovannini M; Harris GJ; Kalamarides M; Karajannis MA; Kim A; Lázaro C; Le LQ; Li W; Listernick R; Martin S; Morrison H; Pasmant E; Ratner N; Schorry E; Ullrich NJ; Viskochil D; Weiss B; Widemann BC; Zhu Y; Bakker A; Serra E
    Am J Med Genet A; 2018 May; 176(5):1258-1269. PubMed ID: 29681099
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.